This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
MGIC Investment (MTG) Q2 Earnings Top, Revenues Miss Estimates
by Zacks Equity Research
MGIC Investment (MTG) Q2 results reflect higher premiums, partially offset by higher expenses
MGIC Investment (MTG) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
MGIC (MTG) delivered earnings and revenue surprises of 50% and 2.66%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
RLI Corporation (RLI) Up 10% in a Year: More Room to Run?
by Tanuka De
RLI Corporation (RLI) is poised to grow on a compelling portfolio, a focus on specialty insurance lines, an impressive record of underwriting profits and effective capital deployment.
Reasons Why Investors Should Retain EverQuote (EVER) Stock Now
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from higher quote requests, the solid performance of automotive insurance providers and financial flexibility.
Here's Why Should You Stay Invested in Assurant (AIZ) Stock
by Zacks Equity Research
Strength in Global Lifestyle business, growth in fee-based capital-light businesses and solid capital management poise Assurant (AIZ) well for growth.
Here's Why Investing in MGIC Investment (MTG) is Prudent Now
by Zacks Equity Research
MGIC Investment (MTG) is poised to gain from a favorable loss reserve development, higher consolidated investment portfolio and investment yields and effective capital deployment.
Marsh & McLennan (MMC) Agency Unit Takes Over CS Insurance
by Zacks Equity Research
Marsh & McLennan's (MMC) Marsh McLennan Agency is likely to benefit from enhanced product offerings, thanks to its CS Insurance acquisition.
Should Value Investors Buy Cigna (CI) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
American Equity (AEL) Up 21% in a Year: More Room to Run?
by Zacks Equity Research
A compelling product portfolio, increasing popularity of index products in the market, focus on expansion into new verticals, solid balance sheet and effective capital deployment continue to drive American Equity Investment Life Holding (AEL).
Why You Should Hold on to Prudential Financial (PRU) Stock
by Zacks Equity Research
Prudential Financial (PRU) benefits from its international presence, favorable underwriting results, higher earnings from joint venture investments and effective capital deployment
Arthur J. Gallagher (AJG) Up 17% in a Year: More Room to Run?
by Zacks Equity Research
Strong performing Brokerage and Risk Management segments, strategic buyouts to capitalize on growing markets opportunities, effective capital deployment and upbeat guidance continue to drive Arthur J. Gallagher (AJG).
Regional Management (RM) Taps Indiana, Grows Base to 15th State
by Zacks Equity Research
With the expansion in Indiana, people with limited access to consumer credit are expected to benefit from Regional Management's (RM) secured credit products.
Here's Why You Should Add MetLife (MET) to Your Portfolio Now
by Zacks Equity Research
MetLife (MET) continues to benefit on the back of strong VII driving its margins, varied product launches, direct expense ratio below its targeted level and a strong cash position.
Here's Why Hold Strategy is Appropriate for Radian Group (RDN)
by Zacks Equity Research
Radian Group (RDN) is poised to grow due to well-performing real estate services and valuation products, favorable growth estimates and effective capital deployment.
Is MetLife (MET) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Owl Rock Capital's (ORCC) Portfolio Company Acquires Liberty
by Zacks Equity Research
Owl Rock Capital (ORCC) expects the acquisition to create a premier equipment finance platform, which will be responsible for providing tailored financial solutions for the clients.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is MGIC Investment (MTG) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Assurant (AIZ) Rallies 15% YTD: Can It Retain the Momentum?
by Zacks Equity Research
The well-performing Global Lifestyle business, growth in fee-based capital-light businesses and solid capital management continue to drive Assurant (AIZ).
3 Reasons Why MGIC (MTG) Is a Great Growth Stock
by Zacks Equity Research
MGIC (MTG) possesses solid growth attributes, which could help it handily outperform the market.
Wall Street Analysts Believe MGIC (MTG) Could Rally 32%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for MGIC (MTG) points to a 32.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Should You Retain Brighthouse (BHF) Stock in Your Portfolio?
by Zacks Equity Research
Brighthouse (BHF) is well poised for growth on the back of higher underwriting margin, strong annuity sales, lower expenses and prudent capital deployment.
Reasons to Hold Trupanion (TRUP) Stock in Your Portfolio Now
by Zacks Equity Research
Trupanion (TRUP) is poised to grow on a change in the attitude of pet owners who are focusing on pets' health and well-being in an underpenetrated pet insurance market, product launches and extended operating boundaries.
MGIC Investment (MTG) is a Top-Ranked Growth Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Should You Retain EverQuote (EVER) Stock in Your Portfolio?
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from higher quote requests, solid performance of automotive insurance providers and sufficient liquidity.